Data / Form D filings / STEMLINE THERAPEUTICS INC
STEMLINE THERAPEUTICS INC: Form D filings
STEMLINE THERAPEUTICS INC, a pharmaceuticals company in New York, NY, filed 3 Form D notices with the SEC between 2010 and 2012. The latest, on January 17, 2012, reports $740,000 sold of an offering with no set size to 16 investors.
Find out what STEMLINE THERAPEUTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1675 YORK AVENUE, SUITE 34-L, New York, NY, 10128
- Phone
- (212) 531-5969
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1264587
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 17, 2012 | New notice | Indefinite | $740,000 | Indefinite | 16 | Jan 2, 2012 | sec.gov |
| Apr 27, 2010 | New notice | $600,000 | $600,000 | $0 | 20 | Apr 14, 2010 | sec.gov |
| Mar 29, 2010 | New notice | $1,250,000 | $1,250,000 | $0 | 5 | Mar 16, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ronald Bentsur | Director | |
| Ivan Bergstein, M.D. | Executive Officer, Director |
Other pharmaceuticals companies in New York that filed recently
- NBO Pharma Inc. $238,000 · Nov 9, 2026
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Jan 16, 2012 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what STEMLINE THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.